Every SEC Form 3/4/5 on record for this filer (CIK 1475714) — 4 issuers, 68 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Director | 2017-06-08 → 2026-02-18 | 12 | −$1M |
| ACLX | Arcellx, Inc. | Director · lapsed | 2022-02-03 → 2022-02-09 | 2 | — |
| NLTX | Neoleukin Therapeutics, Inc. | Director · lapsed | 2019-08-12 → 2021-05-13 | 4 | — |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Director · lapsed | 2015-08-19 → 2019-09-04 | 34 | −$12M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PTGX | 2026-02-17 | Sell | 18,000 | $82.42 | $1M | 7,825 |
1 of 4 issuers are covered and open a security page; the rest are on file here only.